In 2022, Spikevax Inj. by Moderna Korea Inc. was the leading pharmaceutical product in South Korea based on a production value of about 913 billion South Korean won. This was followed by Spikevax 2 Inj. by the same producer, and Remsima Inj. 100mg by Celltrion Inc.
Leading pharmaceutical products in South Korea in 2022, by production value (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in South Korea
Overview
7
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Basic Statistic Pharmaceutical spending as share of GDP South Korea 2000-2022
- Basic Statistic Pharmaceutical spending per capita in South Korea 2000-2022
- Premium Statistic Pharmaceutical medications sales South Korea 2019-2022
- Premium Statistic Pharmaceutical medications taken in South Korea 2019-2022
- Premium Statistic Number of pharmaceutical manufacturers South Korea 2012-2022
Production and distribution
6
- Basic Statistic Pharmaceutical production value South Korea 2012-2022
- Premium Statistic OTC drug products production value South Korea 2012-2022
- Premium Statistic Prescription drug products production value South Korea 2012-2022
- Premium Statistic Leading pharmaceutical products South Korea 2022, by production value
- Premium Statistic Number of pharmaceutical distributors South Korea 2012-2022
- Premium Statistic Number of pharmaceutical distributors South Korea 2022, by type
International trade
6
- Premium Statistic Pharmaceutical export value from South Korea 2012-2022
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2022, by export value
- Premium Statistic Biopharmaceuticals export value from South Korea 2012-2022
- Premium Statistic Pharmaceutical import value in South Korea 2012-2022
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2022, by import value
- Premium Statistic Biopharmaceutical import value in South Korea 2012-2022
Key players
6
- Premium Statistic Leading pharmaceutical businesses South Korea 2023, by revenue
- Premium Statistic Sales revenue Yuhan 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2023
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Sales revenue Kwang Dong Pharmaceutical 2013-2023
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
Pharmaceutical drug consumption
5
- Premium Statistic Pharmaceutical level 1 drugs consumed South Korea 2022, compared to OECD
- Premium Statistic Value of pharmaceutical level 1 drugs consumed South Korea 2022, compared to OECD
- Premium Statistic Major pharmaceutical level 1 drugs consumed South Korea 2022
- Premium Statistic Major pharmaceutical level 2 drugs consumed South Korea 2022
- Premium Statistic Major pharmaceutical level 3 drugs consumed South Korea 2022
Further related statistics
17
- Leading pharmaceutical companies South Korea 2022, by production value
- Increment share among life sciences companies in India 2016-2019
- Therapeutic sectors for drug products South Korea 2019, by production value
- Number of employees in the South Korean pharmaceutical industry 2019, by sector
- Share of employees in the South Korean pharmaceutical industry 2014, by sector
- Responsibility of pharmaceutical firms to provide complementary services 2013
- Importance of digital health strategy objectives for pharma companies 2013
- Leading five global anti-viral products by revenue 2017 and 2024
- Best time for pharmaceutical companies to contact patient 2013
- Digital health strategy priorities for pharma companies 2013
- Global proportion of researchers at pharma companies with dual relationships 2014
- Preferred services from a pharmaceutical company 2013
- Leading global pharmaceutical risers based on share price 2022
- Services from pharma companies to manage disease or health issue 2013
- Top ten pharmaceutical merger and acquisition deals by value 2014
- Satisfaction with own cost for healthcare in the U.S. 2002-2023
- 1-year probability of default median for public U.S. healthcare industries 2020-2021
Further Content: You might find this interesting as well
Statistics
- Leading pharmaceutical companies South Korea 2022, by production value
- Increment share among life sciences companies in India 2016-2019
- Therapeutic sectors for drug products South Korea 2019, by production value
- Number of employees in the South Korean pharmaceutical industry 2019, by sector
- Share of employees in the South Korean pharmaceutical industry 2014, by sector
- Responsibility of pharmaceutical firms to provide complementary services 2013
- Importance of digital health strategy objectives for pharma companies 2013
- Leading five global anti-viral products by revenue 2017 and 2024
- Best time for pharmaceutical companies to contact patient 2013
- Digital health strategy priorities for pharma companies 2013
- Global proportion of researchers at pharma companies with dual relationships 2014
- Preferred services from a pharmaceutical company 2013
- Leading global pharmaceutical risers based on share price 2022
- Services from pharma companies to manage disease or health issue 2013
- Top ten pharmaceutical merger and acquisition deals by value 2014
- Satisfaction with own cost for healthcare in the U.S. 2002-2023
- 1-year probability of default median for public U.S. healthcare industries 2020-2021
MFDS (South Korea). (December 28, 2023). Leading pharmaceutical products in South Korea in 2022, by production value (in billion South Korean won) [Graph]. In Statista. Retrieved May 13, 2024, from https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/
MFDS (South Korea). "Leading pharmaceutical products in South Korea in 2022, by production value (in billion South Korean won)." Chart. December 28, 2023. Statista. Accessed May 13, 2024. https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/
MFDS (South Korea). (2023). Leading pharmaceutical products in South Korea in 2022, by production value (in billion South Korean won). Statista. Statista Inc.. Accessed: May 13, 2024. https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/
MFDS (South Korea). "Leading Pharmaceutical Products in South Korea in 2022, by Production Value (in Billion South Korean Won)." Statista, Statista Inc., 28 Dec 2023, https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/
MFDS (South Korea), Leading pharmaceutical products in South Korea in 2022, by production value (in billion South Korean won) Statista, https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/ (last visited May 13, 2024)
Leading pharmaceutical products in South Korea in 2022, by production value (in billion South Korean won) [Graph], MFDS (South Korea), December 28, 2023. [Online]. Available: https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/